Morcellator Cancer Lawsuits
Power morcellators are surgical rotating blade devices used for grinding uterine fibroids into tiny fragments. The fragments can then be suctioned out from the abdomen through a small incision. Unfortunately, the design of the previously FDA-approved morcellator often leaves tiny fragments of tissue behind, which might be cancerous and easily spread. In addition, many doctors have been negligent in their actions by not determining if the uterine fibroids are cancerous before using the device.
Attorneys for Women Who Have Developed Cancer Following a Power Morcellation Procedure
The FDA (Food & Drug Administration) has warned women, doctors and medical device manufacturers that power morcellators may be spreading cancer that was previously undetected. This issued warning is leading to numerous investigations of women with diagnosed leiomyosarcoma, who have had their uterine fibroids removed by a doctor using a power morcellator.
Since the 1990s, hundreds of thousands of women have had fibroid tumor removal and hysterectomies each year. In fact, many hysterectomies are performed as a way to treat uterine fibroids. The FDA believes that leiomyosarcoma, a rare deadly cancer, may be spread throughout a woman’s abdominal cavity as a result of fibroid tumor removal or hysterectomies from procedures using a power morcellator.
Rosenfeld Injury Lawyers LLC is committed to helping women with leiomyosarcoma and other forms of cancer following a morcellator procedure get the compensation they are entitled to for their medical care and non-economic expenses. We invite you to contact our office for a free case evaluation and frank discussion of your legal rights. We are also available to discuss the status of lawsuits involving power morcellators.
Many doctors and medical device manufacturers are failing to warn patients of the high level of risk involved in morcellators used to perform uterine fibroid removal and hysterectomies. Many hospitals across the United States have stopped using the medical device since long before the FDA warning.
Jama (The Journal of the American Medical Association) has published articles on the risks involved in minimally invasive power uterine morcellation, and the significant risks that may be posed for any woman experiencing undetected uterine cancer. Cancer cells and fibroid tumors seem to be easily spread throughout the pelvis and abdomen areas when the uterus is cut with the power morcellator. This is placing the health of women having the procedure at extreme serious risk. Since the late 1990s, various companies have marketed morcellators. Some of these companies include:
- Johnson & Johnson
- Blue Endo
- Lumenis Inc.
- Interlace Medical
- LiNA Medical
- Richard Wolf
- Smith & Nephew
Since the power morcellation devices were first approved for use by the Food and Drug Administration in 1995, the percentage of uterine sarcoma has been relatively low (0.2 percent) from the total number of women that have had uterine fibroids removed. This is because doctors have not found reliable and easy methods for testing for this specific cancer.
In April 2014, the Food & Drug Administration announced an advisory panel would soon convene, investigating the correlation between the spread of uterine cancer and the use of a power morcellator. The agency continues to discourage morcellation as a procedure for fibroid removal or hysterectomies. As a result, Johnson & Johnson has temporarily suspended any sales of its morcellator device until it receives further guidance from the FDA.
Presently, there are no FDA recalls of this device.
Potential Lawsuits for Cancers Spread by Morcellators
Many women are taking legal steps to seek financial recompense after being diagnosed with specific cancers including LMS (leiomyosarcoma) uterine sarcoma. This is because it is believed that many cancers including LMS might have been spread during a variety of procedures including:
- Uterine Fibroid Removal (Macroscopic Myomectomy)
- Robotic Hysterectomy
- Laparoscopic Supercervical Hysterectomy
Because morcellator techniques continue to undergo critical scrutiny concerning their safety, many lawsuits against the device manufacturers and doctors have been successful. This is because these medical device manufacturers either new, or should have known, the serious associated risks of using the device for uterine fibroid removal surgery and a hysterectomy.
In addition, there have long been safer alternatives to treating uterine fibroid tumors. Because of that, morcellator manufacturers are thought to have withheld crucial information from women and the medical community at large, which likely caused thousands of patients to suffer advanced stages of cancer. As a result, many women have experience a diminished quality of their overall health, or had their life shortened as a result of the procedure.
Chicago Medical Device Defect Attorneys Committed to Prosecuting Power Morcellator Lawsuits
Many women have developed advanced stages of parasitic fibroids and metastases cancer after a power morcellation procedure. The mental, emotional and physical strain associated with needed subsequent procedures and treatments along with a worsening prognosis have cause a significant negative impact on the quality of the patient’s life. As a result, these victims involved in a power morcellator lawsuit are likely eligible for financial compensation to cover a variety of expenses and damages. These include:
- Ongoing medical expenses
- Hospital costs
- Lost wages
- Lifestyle stress
- Wrongful death
Rosenfeld Injury Lawyers LLC are experienced in medical malpractice and medical device litigation are actively investigating and prosecuting morcellation cancer lawsuits. Our Chicago law office provides a free initial legal consultation and case evaluation to women suffering from devastating leiomyosarcoma uterine sarcoma likely caused by a morcellator. Attorneys can discuss a variety of available legal options, and ways to protect the rights of the victim of a dangerous medical device.